Literature DB >> 527263

Leucoattractants enhance complement receptors on human phagocytic cells.

A B Kay, E J Glass, D M Salter.   

Abstract

The N-formyl-methionyl peptides, F-Met-Leu-Phe, F-Met-Met-Phe and F-Met-Phe, when tested at differing concentrations, proportionally increased both in vitro cell locomotion and the expression of surface receptors for C3b on human peripheral blood neutrophils and monocytes. In contrast, the unformylated peptides, Met-Leu-Phe and Me-Met-Phe, had no chemotactic or complement receptor-enhancing activity at comparable concentrations. Casein and supernatants from human lymphocytes (cultured either in the presence or absence of phytohaemagglutinin), also recognized as chemotactic agents for human neutrophils and monocytes, enhanced C3b receptors on these cells in a similar dose-dependent fashion. These data, taken together with our previous findings with the eosinophil, suggest that in addition to promoting cell locomotion a further biological function of leucoattractants may be their capacity to render complement receptors more freely available thereby increasing the magnitude of adhesion of phagocytic cells to opsonized particles.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 527263      PMCID: PMC1537863     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  An improved method for the in vitro evaluation of monocyte leukotaxis.

Authors:  P B Campbell
Journal:  J Lab Clin Med       Date:  1977-08

2.  The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors.

Authors:  A R Anwar; A B Kay
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

3.  The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen.

Authors:  A B Kay; D S Pepper; R McKenzie
Journal:  Br J Haematol       Date:  1974-08       Impact factor: 6.998

4.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

5.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

6.  Enhancement of human eosinophil complement receptors by pharmacologic mediators.

Authors:  A R Anwar; B Kay
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

7.  Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines.

Authors:  E M Shevach; R Herberman; M M Frank; I Green
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

8.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

9.  Antigen-induced locomotor responses in lymphocytes.

Authors:  P C Wilkinson; D M Parrott; R J Russell; F Sless
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

10.  Monocyte chemotaxis in bronchial carcinoma and cigarette smokers.

Authors:  A B Kay; J G McVie
Journal:  Br J Cancer       Date:  1977-10       Impact factor: 7.640

View more
  33 in total

Review 1.  Leukocyte activation following IgE dependent mechanisms in bronchial asthma.

Authors:  S R Durham
Journal:  Clin Rev Allergy       Date:  1989

2.  Enhanced granulocyte cytotoxicity by mediators derived from anti-IgE-stimulated human leucocytes.

Authors:  R Moqbel; A J MacDonald; A B Kay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  Effects of chemotactic peptide f-Met-Leu-Phe (FMLP) on C3b receptor (CR1) expression and phagocytosis of microspheres by human neutrophils.

Authors:  J D Ogle; J G Noel; R M Sramkoski; C K Ogle; J W Alexander
Journal:  Inflammation       Date:  1990-06       Impact factor: 4.092

4.  Neutrophils from Both Susceptible and Resistant Mice Efficiently Kill Opsonized Listeria monocytogenes.

Authors:  Michelle G Pitts; Travis A Combs; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

5.  Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum.

Authors:  T R Kozel; G S Pfrommer; D Redelman
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

6.  Characteristics of iC3b binding to human polymorphonuclear leucocytes.

Authors:  D L Gordon; G M Johnson; M K Hostetter
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

7.  Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro.

Authors:  R Moqbel; A J MacDonald; A B Kay
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

8.  C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E De Vries; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient.

Authors:  O Stendahl; B I Coble; C Dahlgren; J Hed; L Molin
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

10.  Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis.

Authors:  J Lee; R M Hakim; D T Fearon
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.